Publication | Open Access

Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension

Antioxidative EffectsMetabolic SyndromeHypertensionCardiovascular DiseaseAntihypertensive TherapyPhysiologyPharmacologyCardiovascular PharmacologyHigh-risk HypertensionEndothelial DysfunctionVascular BiologyPharmacotherapyAngiotensin Receptor BlockerMedicineAtherosclerosisOxidative StressHealth Sciences